Most recent update: Monday, September 23, 2019 - 09:10

Bariatric News - Cookies & privacy policy

You are here

Stretta ten-year results

Stretta ten-year results shows 72% of patients off medications

The need for a treatment option for this type of patient that does not require daily long-term medications or surgery

Mederi Therapeutics has announced that new ten-year patient follow-up data on Stretta therapy presented at this year's United European Gastroenterology Week (UEGW) in Vienna, Austria, showed significant, durable relief from GERD symptoms and elimination of Proton Pump Inhibitors (PPIs) use in 71.9% of patients ten-years post-Stretta. The results, presented by lead author, Dr Luca Dughera, University of Torino, Italy,  was presented in a study entitled, "The use of non-ablative RF energy (Stretta) for the treatment of GERD. Ten years follow-up results.”

Luca Dughera

About 30% of patients with GERD still experience symptoms despite standard medications such as PPIs, and many more patients are concerned about potential risks of these long-term medications. According to the company, Stretta is an ideal treatment for these patients who still have GERD despite medications but do not want to have surgery.

The study followed 251 patients, including 57 patients who reached ten-year follow-up, and found a significant and durable effect of Stretta treatment. Findings included:

  • A significant improvement in both heartburn and GERD quality of life (HRQL) scores
  • 71.9% (41/57) patients completely off PPIs ten-years after a Stretta procedure
  • Stretta was effective in resolving extra oesophageal symptoms of GERD

Stretta is a non-surgical procedure for GERD that delivers low power, low temperature RF energy to remodel the valve known as the lower oesophageal sphincter (LES) at the junction of the oesophagus and the stomach. Stretta reduces or eliminates regurgitation of stomach contents by improving muscle tone and reducing random openings of the LES that are known to cause GERD. Stretta treatment results in elimination or significant reductions of GERD symptoms and medication use, and significant improvement in a patient's quality of life.

Stretta therapy delivers low power, low temperature radiofrequency energy to remodel the valve known as the lower oesophageal sphincter (LES) at the junction of the oesophagus (Credit: PRNewsFoto/Mederi Therapeutics Inc.)

In the study, Dughera and colleagues recognised the need for a treatment option for this type of patient that does not require daily long-term medications or surgery, especially in younger populations.

“Younger patients with chronic GERD don't wish to be on a lifetime of daily medications  and are interested in avoiding surgery," said Dughera. "Stretta has been widely documented in clinical studies as safe and effective, and has been supported with guidelines by both SAGES and ASGE. It is a viable treatment option that should be offered to GERD sufferers," he added.

This ten-year data is consistent with another ten-year study by Noar et al, published in Surgical Endoscopy in 2014, that reported that 64% of patients were off medications ten-year post-Stretta, with significant improvement in GERD HRQL scores and a high level of patient satisfaction.

Want more stories like this? Subscribe to Bariatric News!

Bariatric News
Keep up to date! Get the latest news in your inbox. NOTE: Bariatric News WILL NOT pass on your details to 3rd parties. However, you may receive ‘marketing emails’ sent by us on behalf of 3rd parties.